Eventide Asset Management, LLC Collegium Pharmaceutical, Inc Transaction History
Eventide Asset Management, LLC
- $5.22 Billion
- Q4 2024
A detailed history of Eventide Asset Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Eventide Asset Management, LLC holds 2,638,702 shares of COLL stock, worth $77.7 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
2,638,702
Previous 2,635,406
0.13%
Holding current value
$77.7 Million
Previous $102 Million
25.76%
% of portfolio
1.45%
Previous 1.79%
Shares
11 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
37.4MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$171 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$69.2 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$67.2 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$63.1 Million0.15% of portfolio
-
Invesco Ltd. Atlanta, GA1.78MShares$52.3 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.01B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...